OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Lightspeed is in discussions to lead the funding round, sources say.
Lightspeed is in discussions to lead the funding round, sources say.
Similar Posts
The AI gold rush is pulling private wealth into riskier, earlier bets
0 Comments
On a recent episode of Equity, we talked to Arena Private Wealth to explore a growing trend:…
What the jury will actually decide in the case of Elon Musk vs. Sam Altman
Here’s what the biggest tech court case of the year is all about.
Origin Lab raises $8M to help video game companies sell data to world-model builders
Origin Lab will serve as a marketplace where AI labs can buy high-quality licensed data, and video-game…
RJ Scaringe has raised more than $12 billion across three startups and investors still want more
Founder and CEO RJ Scaringe has a knack for raising money. So far, his three startups have…
Why Apple’s slow-and-steady AI bet is starting to look pretty smart
Can Apple’s new AI glow up put to bed accusations that it’s losing an all-important industry race?
DOJ claims xAI’s unpermitted gas turbines are a matter of ‘national, economic, and energy security’
The Justice department says the Pentagon needs xAI to keep using its unpermitted gas turbines.